Dublin, Nov. 23, 2020 (GLOBE NEWSWIRE) -- The "India In-vitro Fertilization Market By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF), By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryosystem, Others), By Donor, By Infertility, By Embryo, By End User, By Region, Competition, Forecast & Opportunities, FY2026" report has been added to ResearchAndMarkets.com's offering.
The Indian In-vitro Fertilization Market is forecast to grow at a formidable rate of around 13% and surpass $1 billion market by FY 2026.
The country's in-vitro fertilization market is driven by improving healthcare infrastructure and rising availability of modern healthcare facilities at affordable prices. This fact is also giving rise to medical tourism thereby propelling the in-vitro fertilization market in the country.
Additionally, changing lifestyle patterns are leading to various diseases such as PCOS and other kinds of reproductive diseases. Furthermore, increasing number of single super specialty hospitals is projected to fuel the market over the next few years. Besides, growing awareness towards male infertility in the country is expected to positively influence the market over the next few years.
The Indian In-vitro Fertilization Market is segmented based on technique, product, donor, infertility, embryo, end-user, and region . Based on technique, the market can be split into ICSI IVF and Non-ICSI/Traditional IVF. The ICSI IVF segment is expected to dominate the market during the forecast period.
This can be ascribed to the benefits associated with this technique such as better fertilization and minimization of multi-nucleation since only one sperm and one egg is involved in this technique. Additionally, there is no acrosome reaction taking place in this technique.
Based on end-user, the market can be categorized into fertility clinics, hospitals and others. The fertility clinics segment is expected to dominate the market owing to the growing consumer preference for availing treatment at these facilities. Additionally, growing penetration of fertility clinics & centers chains is further expected to fuel the market growth through FY2026.
Companies Mentioned
- Merck India (Merck KGaA)
- Origio India Pvt. Ltd. (Cooper Surgical)
- IMV India Pvt. Ltd (Hamilton Thorne, Ltd.)
- Thermo Fisher Scientific India Pvt. Ltd.
- Travancore Trade Links (Vitrolife AB)
- Cook Medical India
- Morpheus Life Sciences Pvt. Ltd.
- Max Healthcare Pvt. Ltd.
- Olympus Medical Systems India Pvt. Ltd.
- Fujifilm India Private Limited
Years considered for this report:
- Historical Years: FY2016-FY2019
- Base Year: FY2020
- Estimated Year: FY2021
- Forecast Period: FY2022-FY2026
Key Target Audience:
- In-vitro fertilization fertility centers, hospitals/clinics and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to in-vitro fertilization
- Market research and consulting firms
Report Scope:
In this report, the Indian In-vitro Fertilization Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Market, By Technique:
- ICSI
- Non-ICSI/ Traditional IVF
Market, By Products:
- IVF Culture Media
- ICSI Machine
- IVF Incubators
- Cryosystem
- Others
Market, By Donor:
- Fresh Non-Donor
- Frozen Non-Donor
- Frozen Donor
- Fresh Donor
Market, By Infertility:
- Male
- Female
Market, By Embryo:
- Fresh Embryo
- Frozen-thawed Embryo
Market, By End-User:
- Fertility Clinics
- Hospitals
- Others
Market, By Region:
- North
- South
- East
- West
For more information about this report visit https://www.researchandmarkets.com/r/cl7ini
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.